Development and application of PI3K assays for novel drug discovery

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Expert Opinion on Drug Discovery

• Publication date

  2015-01-20

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1517/17460441.2015.997205PMID 25547459
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• New in-capillary electrophoretic kinase assays to evaluate inhibitors of the PI3k/Akt/mTOR signaling pathway

  2014cited by this paper
• Development of phosphocellulose paper-based screening of inhibitors of lipid kinases: case study with PI3Kβ.

  2014cited by this paper
• Targeting the PI3K/mTOR Pathway in Pediatric Hematologic Malignancies

  2014cited by this paper
• ATP competition of PI3K inhibitors using phosphocellulose paper approach

  2014cited by this paper
• A Homogeneous, High-Throughput Assay for Phosphatidylinositol 5-Phosphate 4-Kinase with a Novel, Rapid Substrate Preparation

  2013cited by this paper
• Inhibition of phosphoinositide 3‐kinase γ attenuates inflammation, obesity, and cardiovascular risk factors

  2013cited by this paper
• Signaling by the phosphoinositide 3-kinase family in immune cells.

  2013cited by this paper
• Measuring PI3K lipid kinase activity.

  2012cited by this paper
• Current clinical development of PI3K pathway inhibitors in glioblastoma.

  2012cited by this paper
• A Yeast-Based In Vivo Bioassay to Screen for Class I Phosphatidylinositol 3-Kinase Specific Inhibitors

  2012cited by this paper
• Clinical development of phosphatidylinositol 3-kinase inhibitors for cancer treatment

  2012cited by this paper
• PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances.

  2012cited by this paper
• LY294002 induces G0/G1 cell cycle arrest and apoptosis of cancer stem-like cells from human osteosarcoma via down-regulation of PI3K activity.

  2012cited by this paper
• The Therapeutic Potential for PI3K Inhibitors in Autoimmune Rheumatic Diseases

  2012cited by this paper
• PI3K inhibitors in cardiovascular disease.

  2011cited by this paper
• Fluorescence polarization assays in small molecule screening

  2011cited by this paper
• Kinetic analysis of PI3K reactions with fluorescent PIP2 derivatives

  2011cited by this paper
• Small-molecule inhibitors of the PI3K signaling network.

  2011cited by this paper
• Phosphatidylinositol 3-kinase: the oncoprotein.

  2010cited by this paper
• The PI3K pathway as drug target in human cancer.

  2010cited by this paper
• Phosphoinositide 3-kinases and their role in inflammation: potential clinical targets in atherosclerosis?

  2009cited by this paper
• Targeting PI3K signalling in cancer: opportunities, challenges and limitations

  2009cited by this paper
• Fluorescence polarization and time-resolved fluorescence resonance energy transfer techniques for PI3K assays.

  2009cited by this paper
• Evaluating the Utility of a Bioluminescent ADP-Detecting Assay for Lipid Kinases

  2009cited by this paper
• High-Throughput, Cell-Free, Liposome-Based Approach for Assessing In Vitro Activity of Lipid Kinases

  2009cited by this paper
• HTRF: A Technology Tailored for Drug Discovery –A Review of Theoretical Aspects and Recent Applications

  2009cited by this paper
• PI3Kγ regulates cartilage damage in chronic inflammatory arthritis

  2009cited by this paper
• Evaluating PI3 Kinase Isoforms Using Transcreener™ ADP Assays

  2008cited by this paper
• A High-Throughput Liposome Substrate Assay with Automated Lipid Extraction Process for PI 3-Kinase

  2008influential reference
• Biochemical assays for selectivity profiling across the entire PI3 kinase family

  2008cited by this paper
• Scintillation Proximity Assays in High-Throughput Screening

  2008cited by this paper
• Characterization of PI3K class IA isoforms with regulatory subunit p55alpha using a scintillation proximity assay.

  2008cited by this paper
• The Use of AlphaScreen Technology in HTS: Current Status

  2008cited by this paper
• Phosphoinositide 3-kinase signalling in the vascular system.

  2008cited by this paper
• The challenge of selecting protein kinase assays for lead discovery optimization

  2008cited by this paper
• A membrane capture assay for lipid kinase activity

  2007cited by this paper
• Pharmacologic characterization of a potent inhibitor of class I phosphatidylinositide 3-kinases.

  2007cited by this paper
• Synthesis and biological evaluation of imidazo[1,2-a]pyridine derivatives as novel PI3 kinase p110alpha inhibitors.

  2007cited by this paper
• Bioluminescent Assays for High-Throughput Screening

  2007cited by this paper
• Phosphoinositide 3-kinases as a common platform for multi-hormone signaling.

  2007cited by this paper
• PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond?

  2007cited by this paper
• Synthesis and biological evaluation of imidazo[1,2-a]pyridine derivatives as novel PI3 kinase p110α inhibitors

  2007cited by this paper
• The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism

  2006cited by this paper
• Type I phosphoinositide 3-kinases: potential antithrombotic targets?

  2006cited by this paper
• A Robust Screen for Inhibitors and Enhancers of Phosphoinositide-3 Kinase (PI3K) Activities by Ratiometric Fluorescence Superquenching

  2006cited by this paper
• Assay of protein kinases using radiolabeled ATP: a protocol

  2006cited by this paper
• Signalling through Class I PI3Ks in mammalian cells.

  2006cited by this paper
• Synthesis and biological evaluation of 4-morpholino-2-phenylquinazolines and related derivatives as novel PI3 kinase p110alpha inhibitors.

  2006cited by this paper
• PI 3-kinase p110beta: a new target for antithrombotic therapy.

  2005cited by this paper
• Blockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis

  2005cited by this paper
• Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis.

  2005cited by this paper
• PI 3-kinase p110β: a new target for antithrombotic therapy

  2005cited by this paper
• Phosphoinositide 3-kinases and the regulation of platelet function.

  2004cited by this paper
• PI3K in lymphocyte development, differentiation and activation

  2003cited by this paper
• Determination of a large number of kinase activities using peptide substrates, P81 phosphocellulose paper arrays and phosphor imaging.

  2003cited by this paper
• A Versatile High-Throughput Screen for Inhibitors of Lipid Kinase Activity: Development of an Immobilized Phospholipid Plate Assay for Phosphoinositide 3-Kinase γ

  2002cited by this paper
• Interfacial enzyme kinetics at the phospholipid/water interface: practical considerations.

  2000cited by this paper
• Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys-802, a residue involved in the phosphate transfer reaction

  1996cited by this paper
• A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002).

  1994cited by this paper
• Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses.

  1993cited by this paper

• A new functional assay reveals that membrane binding is critical for overactivation of the phosphoinositide 3-kinase H1047R mutant.

  2026cites this paper
• Design, Synthesis and Molecular Docking Study of Novel 1,3,5-Triazine and 2-Phenylquinazoline Derivatives as Promising Anticancer Agents

  2025cites this paper
• Targeting hematological malignancies with isoxazole derivatives.

  2024cites this paper
• miR-1908 Dysregulation in Human Cancers

  2022cites this paper
• Controlled microwave-assisted reactions: A facile synthesis of polyfunctionally substituted phthalazines as dual EGFR and PI3K inhibitors in CNS SNB-75 cell line.

  2022cites this paper
• Discovery of Anti-metastatic Chiral Ionone Alkaloid Derivatives Targeting HIF-1α/VEGF/VEGFR2 Pathway.

  2021cites this paper
• Synthesis, in-silico, and in-vitro study of novel chloro methylquinazolinones as PI3K-δ inhibitors, cytotoxic agents

  2021cites this paper
• Microglia Mediated Neuroinflammation: Focus on PI3K Modulation

  2020cites this paper
• Synergistic neuroprotective effect of schisandrin and nootkatone on regulating inflammation, apoptosis and autophagy via the PI3K/AKT pathway.

  2020cites this paper
• Molecular mechanism of dihydrotanshinone I on inhibiting proliferation of human breast cancer MCF ⁃ 7 cells through GPER pathway

  2020cites this paper
• Omipalisib inspired macrocycles as dual PI3K/mTOR inhibitors.

  2020cites this paper
• Involvement of a Novel Organic Cation Transporter in Paeonol Transport Across the Blood-Brain Barrier

  2019cites this paper
• Upstream regulators of phosphoinositide 3‐kinase and their role in diseases

  2019influential citation
• Telmisartan Protects a Microglia Cell Line from LPS Injury Beyond AT1 Receptor Blockade or PPARγ Activation

  2018cites this paper
• Targeted Disruption of NF1 in Osteocytes Increases FGF23 and Osteoid With Osteomalacia‐like Bone Phenotype

  2017cites this paper
• Simultaneous targeting PI3K and PERK pathways promotes cell death and improves the clinical prognosis in esophageal squamous carcinoma.

  2017cites this paper
• The Vascular Endothelial Growth Factor-A phosphorylates Murine Double Minute-2 on its Serine 166 via the Extracellular Signal-Regulated Kinase 1/2 and p90 Ribosomal S6 Kinase in primary human endothelial cells.

  2016cites this paper
• Synthesis and anti-metastatic effects of pregn-17(20)-en-3-amine derivatives.

  2016cites this paper
• Effective PI3K modulators for improved therapy against malignant tumors and for neuroprotection of brain damage after tumor therapy (Review).

  2016cites this paper
• Genetic variations in the PI3K/AKT pathway predict platinum-based neoadjuvant chemotherapeutic sensitivity in squamous cervical cancer.

  2015cites this paper
• Modulation of Huh7.5 Spheroid Formation and Functionality Using Modified PEG-Based Hydrogels of Different Stiffness

  2015cites this paper